EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Coronary Microvascular Dysfunction in Cardiomyopathies: Insights on Clinical and Prognostic Roles

Federico Giacobbe iD, Pierre Meynet iD, Marco Balducci iD, Sergio Capoccia iD, Rino Andrea Cimino iD, Arianna Morena iD, Antonio Dalu iD, Fabrizio D'Ascenzo, Ovidio De Filippo iD, Filippo Novarese, Francesco Bruno iD, Claudia Raineri iD und 9 weitere

Reviews in Cardiovascular Medicine · 26.02.2026 · 27 (2)

DOI: 10.31083/rcm46829 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Reviews in Cardiovascular Medicine, online erschienen am 26.02.2026. Verfasst von Federico Giacobbe und 20 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Cardiovascular and Thoracic Department, Città della Salute e della Scienza, 10126 Turin, Italy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coronary microvascular dysfunction (CMD) is a key driver of ischemia and prognosis across several non-ischemic cardiomyopathies. This review summarizes the main tools for diagnosing microvascular dysfunction and available evidence on CMD incidence and the prognostic role in patients with cardiomyopathies. In dilated cardiomyopathy, CMD is associated with reduced myocardial blood flow, greater fibrosis, adverse remodeling, and worse outcomes. In hypertrophic cardiomyopathy, CMD is highly prevalent and multifactorial (arteriolar remodeling, reduced capillary density, extravascular compression, diastolic dysfunction, and/or left ventricular (LV) outflow obstruction), correlating with fibrosis, heart failure, and arrhythmias/sudden death. In Takotsubo syndrome, CMD appears acute and reversible, with microvascular spasms as a predominant mechanism and plausible pathophysiologic basis of the event. In arrhythmogenic right ventricular cardiomyopathy, preliminary data show a blunted hyperemic response and autonomic abnormalities that may impair microvascular vasodilation. In infiltrative and storage diseases (amyloidosis and Anderson–Fabry disease), CMD is often early, preceding hypertrophy/fibrosis, and contributes to symptoms, contractile dysfunction, and adverse outcomes; in sarcoidosis, microvascular inflammation reduces coronary flow reserve (CFR) and is associated with events. Targeted therapies remain limited; optimization of risk factors and drugs that modulate endothelial/metabolic function (statins, angiotensin converting enzyme (ACE) inhibitors, vasodilating β-blockers, calcium channel blockers, sodium glucose cotransporter 2 (SGLT2) inhibitors) yielded variable signals; device-based and nonpharmacologic strategies are under investigation. In conclusion, integrating microcirculatory assessment improves risk stratification and may furnish future therapeutic targets across cardiomyopathies.

Schlagwörter

Stichwörter der Autor:innen

cardiomyopathiescoronary circulationmicrocirculationmicrovascular angina

Autor:innen und Institutionen

  • Division of Cardiology, Cardiovascular and Thoracic Department, Città della Salute e della Scienza, 10126 Turin, Italy.
  • Division of Cardiology, Department of Medical Sciences, University of Turin, 10126 Turin, Italy.
  • Department of Cardiology, Research, Education and Development Division, Royal Brompton and Harefield Hospitals, SW3 6NP London, UK.
  • Division of Cardiology, San Martino Hospital, University of Genoa, 16132 Genoa, Italy.
  • Department of Cardiology, Hippokration Hospital of Athens, 11527 Athens, Greece.

ORCID-Profile: Federico Giacobbe, Pierre Meynet, Marco Balducci, Sergio Capoccia, Rino Andrea Cimino, Arianna Morena, Antonio Dalu, Ovidio De Filippo, Francesco Bruno, Claudia Raineri, Athanasios Sakalidis, Giuseppe Giannino, Filippo Angelini, Pier Paolo Bocchino, Veronica Dusi, Italo Porto, Gaetano Maria De Ferrari

Zitieren

APA

Giacobbe, F., Meynet, P., Balducci, M., Capoccia, S., Cimino, R. A., Morena, A., Dalu, A., D'Ascenzo, F., De Filippo, O., Novarese, F., Bruno, F., Raineri, C., Conrotto, F., Sakalidis, A., Omedé, P., Giannino, G., Angelini, F., Bocchino, P. P., Dusi, V., …, & De Ferrari, G. M. (2026). Coronary Microvascular Dysfunction in Cardiomyopathies: Insights on Clinical and Prognostic Roles. Reviews in Cardiovascular Medicine, 27(2). https://doi.org/10.31083/rcm46829

Vancouver

Giacobbe F, Meynet P, Balducci M, Capoccia S, Cimino RA, Morena A, et al. Coronary Microvascular Dysfunction in Cardiomyopathies: Insights on Clinical and Prognostic Roles. Reviews in Cardiovascular Medicine. 2026;27(2). doi:10.31083/rcm46829

BibTeX
@article{Giacobbe2026,
  author = {Giacobbe, Federico and Meynet, Pierre and Balducci, Marco and Capoccia, Sergio and Cimino, Rino Andrea and Morena, Arianna and Dalu, Antonio and D'Ascenzo, Fabrizio and De Filippo, Ovidio and Novarese, Filippo and Bruno, Francesco and Raineri, Claudia and Conrotto, Federico and Sakalidis, Athanasios and Omedé, Pierluigi and Giannino, Giuseppe and Angelini, Filippo and Bocchino, Pier Paolo and Dusi, Veronica and Porto, Italo and De Ferrari, Gaetano Maria},
  title = {Coronary Microvascular Dysfunction in Cardiomyopathies: Insights on Clinical and Prognostic Roles},
  journal = {Reviews in Cardiovascular Medicine},
  year = {2026},
  volume = {27},
  number = {2},
  doi = {10.31083/rcm46829}
}
Kostenlos starten →